Peer Review History
| Original SubmissionNovember 1, 2025 |
|---|
|
-->PNTD-D-25-01829 Cost-effectiveness of soil-transmitted helminthiasis intervention programmes: A scoping review PLOS Neglected Tropical Diseases Dear Dr. Okoyo, Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within by Mar 23 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Luis Marcos, MD, MPH, FIDSA Guest Editor PLOS Neglected Tropical Diseases Krystyna Cwiklinski Section Editor PLOS Neglected Tropical Diseases Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-4304-636XX Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-1765-0002 Additional Editor Comments: Reviewers comments should be taken into consideration, a new version will be reviewed. Journal Requirements: 1) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: https://journals.plos.org/plosntds/s/figures 2) We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list. 3) We notice that your supplementary information is included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list. 4) Some material included in your submission may be copyrighted. According to PLOSu2019s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOSu2019s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form. Please respond directly to this email and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility. Once you have responded and addressed all other outstanding technical requirements, you may resubmit your manuscript within Editorial Manager. Potential Copyright Issues: - Figure 2. Please (a) provide a direct link to the base layer of the map (i.e., the country or region border shape) and ensure this is also included in the figure legend; and (b) provide a link to the terms of use / license information for the base layer image or shapefile. We cannot publish proprietary or copyrighted maps (e.g. Google Maps, Mapquest) and the terms of use for your map base layer must be compatible with our CC BY 4.0 license. Note: if you created the map in a software program like R or ArcGIS, please locate and indicate the source of the basemap shapefile onto which data has been plotted. If your map was obtained from a copyrighted source please amend the figure so that the base map used is from an openly available source. Alternatively, please provide explicit written permission from the copyright holder granting you the right to publish the material under our CC BY 4.0 license. If you are unsure whether you can use a map or not, please do reach out and we will be able to help you. The following websites are good examples of where you can source open access or public domain maps: * U.S. Geological Survey (USGS) - All maps are in the public domain. (http://www.usgs.gov) * PlaniGlobe - All maps are published under a Creative Commons license so please cite u201cPlaniGlobe, http://www.planiglobe.com, CC BY 2.0u201d in the image credit after the caption. (http://www.planiglobe.com/?lang=enl) * Natural Earth - All maps are public domain. (http://www.naturalearthdata.com/about/terms-of-use/). Reviewers' Comments: Reviewer's Responses to Questions Key Review Criteria Required for Acceptance? As you describe the new analyses required for acceptance, please consider the following: Methods -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? -Is the population clearly described and appropriate for the hypothesis being tested? -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? -Were correct statistical analysis used to support conclusions? -Are there concerns about ethical or regulatory requirements being met? Reviewer #1: Overall, this is a well written and clear paper. The results are compelling, despite the acknowledged limitations. My main concern or question regarding the methodology is whether the studies that were included based their cost-effectiveness analyses on actual (i.e., measured) costs/benefits or on assumed or estimated ones? Is there a way for the authors to ascertain this for each study and to add it to the paper? For example, the single Brazil study seems to have included inputs from several other studies (even some done in Africa). Minor: 1. Figure 1 describes records marked as ineligible by "automation tools" but these tools are not described in the Methods section. Please clarify. Reviewer #2: the objective is clear with correct statistical analysis Reviewer #3: The research question must be well-defined and aligned with the objectives. There is no consistency between the conclusion and the questions posed at the beginning. Although they chose a scoping review approach, when discussing the economic models used to evaluate these studies, these models are not ultimately considered or mentioned. The title does not accurately reflect the paper's actual purpose, and, most importantly, it fails to specify the geographical areas studied. I would suggest narrowing the scope to Sub-Saharan Africa. ********** Results -Does the analysis presented match the analysis plan? -Are the results clearly and completely presented? -Are the figures (Tables, Images) of sufficient quality for clarity? Reviewer #1: 1. Line 262: please clarify that the "hookworm vaccine" is a hypothetical one, since there currently is no approved vaccine for this STH. 2. Table 2 lists the year of publication for each study, but that doesn't necessarily reflect the time period when the data were collected, since publication could have occurred years later. Would it be possible to include the dates that the studies were conducted or during which the data were collected? Reviewer #2: analysis presented match the analysis plan Reviewer #3: The results should be aligned with the studies. Table 1 should be improved, as it is currently redundant, and I would recommend eliminating the third column. The map presented should have two parts: zones showing areas according to prevalence (high, medium, or low), and, either on the same or a separate map, the number of studies in choropleth maps. If the studies only considered English-language literature, I would remove the data concerning Latin America from the study to avoid drawing erroneous conclusions. ********** Conclusions -Are the conclusions supported by the data presented? -Are the limitations of analysis clearly described? -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? -Is public health relevance addressed? Reviewer #1: Overall, the conclusions appear to be supported by the data presented. Limitations are clearly stated. Reviewer #2: the conclusion supported by data presented, the authors discuss how data can help understanding of strategies for the control of STD. Reviewer #3: The study draws conclusions based on unclear information, such as defining that population-level interventions are more cost-effective than school-level interventions, when Table 1 only identifies two or three studies with those characteristics. The limitations do not mention that the cost-effectiveness analyses that should have been used were not performed, and I believe this should be clearly stated in the limitations. As the authors themselves mention, there are significant biases in the collection and analysis of the data. I suggest improving the analysis, the formulation of the research question, and ensuring consistency throughout the article. ********** Editorial and Data Presentation Modifications? Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”. Reviewer #1: 1. Lines 91-93: how does coformulation of albendazole and ivermectin in a fixed-dose combination provide evidence of effectiveness? I think that what the authors mean to say is that recent evidence from a Phase 2/3 trial (published in TLID) showed improved efficacy of the FDC vs single-dose ALB against T. trichiura. However, the sentence as currently worded does not state this and should be revised for clarity. 2. Line 166: should this be "ratio" instead of "ration" (ICER definition)? Reviewer #2: These data could have been very useful in general. Because of the limitation to English litterature its sound that in area where STD and others parasite like Loa loa co exist. strategies may be different. I will suggest that the authors expand discussion on this particular situation ( IVM= ivermetin, may be use with caution in loiasis endemic countries ....) where economic benefits of combined ALB/IVM needs further studies. Reviewer #3: (No Response) ********** Summary and General Comments Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed. Reviewer #1: (No Response) Reviewer #2: This study map the area covered by mass drug administration for STD control in the world. Its show economic value of community based control over school chidren based control. its demonstrate that community based control is more economical than school children based strategy. We suggest to the authors to expand their discussion in area where STD co exist whit filaria Loa loa Reviewer #3: I believe that while the article addresses an important topic such as the cost-effectiveness of programs, it fails to integrate the necessary methods for conducting such analyses through a systematic review. I suggest that the title be revised, clearly stating that it is merely a description and not an analysis, as is the conclusion reached. ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission:--> -->-->While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.-->--> After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.--> Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols -->
|
| Revision 1 |
|
Dear Dr Okoyo, We are pleased to inform you that your manuscript 'Cost-effectiveness of soil-transmitted helminthiasis intervention programmes: A scoping review' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Luis Marcos, MD, MPH, FIDSA Guest Editor PLOS Neglected Tropical Diseases Krystyna Cwiklinski Section Editor PLOS Neglected Tropical Diseases Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-4304-636XX Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-1765-0002 *********************************************************** Authors have addressed properly all feedback provided by reviewers. Article sounds now more scientifically correct. p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 16.0px; font: 14.0px Arial; color: #323333; -webkit-text-stroke: #323333}span.s1 {font-kerning: none |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .